Immune Profiling

 

 

The Immune Profiling Conference brings together pharma and biotech, together with leading research institutes. They’re meeting to discuss how profiling of the immune system using high throughput technologies can aid therapeutic design and treatment strategies in infectious and non-infectious diseases including cancer. If you offer platforms or technologies that can help advance or predict the outcome of these companies pipeline, the event will allow you to showcase your services and technologies directly to them and generate awareness of what you do with key decision makers. VISIT WEBSIT

 

2018 AGENDA

 

 

Immune Profiling, Thursday 5 April 2018

Immune Profiling
09:00

Chair’s opening remarks

Analysing Immune Profiles for Cancer Treatment

Panel discussion
Immune Profiling
09:10

Panel: Engineering CAR-T & TCR cells for cancer therapy

  • How can you additionally modify T-cells beyond the T cell receptor/ the CAR to behave in a more controlled and/or potent fashion?
  • The challenge of keeping the manufacturing process simple, whilst maintaining the effectiveness of the product
  • The use of molecular imaging to track CAR T cells: Where do they go in the body? Do they accumulate in the tumor?
  • Mitigating side effects: controlling neurotoxicity etc.
  • Biomarkers – Identifying patients that will respond to treatment
  • Combination strategies
Dr Ezio Bonvini
Immune Profiling
10:10

Combinatorial immunotherapy: expanding the horizons with bispecific DART® molecules

10:40

Networking coffee break

Immune Profiling
11:30

Cancer neoantigens and their use in personalized cancer vaccines

Dr Bahram Bob Valamehr
Immune Profiling
12:00

Development of off-the-shelf immunotherapy from pluripotent cells

  • Pluripotent Cell Derived T and NK cells: Cornerstone Approach for Off-the-Shelf Cancer Immunotherapy
  • Use of small molecules and biologics, ex vivo, to optimize the biological properties and therapeutic function of hematopoietic cells
12:30

Networking Lunch & Poster Session

AFTERNOON PLENARY OF CONGRESS

last published: 22/Nov/17 13:35

Immune Profiling, Thursday 5 April 2018

Immune Profiling
09:00

Chair’s opening remarks

Analysing Immune Profiles for Cancer Treatment

Panel discussion
Immune Profiling
09:10

Panel: Engineering CAR-T & TCR cells for cancer therapy

  • How can you additionally modify T-cells beyond the T cell receptor/ the CAR to behave in a more controlled and/or potent fashion?
  • The challenge of keeping the manufacturing process simple, whilst maintaining the effectiveness of the product
  • The use of molecular imaging to track CAR T cells: Where do they go in the body? Do they accumulate in the tumor?
  • Mitigating side effects: controlling neurotoxicity etc.
  • Biomarkers – Identifying patients that will respond to treatment
  • Combination strategies
Dr Ezio Bonvini
Immune Profiling
10:10

Combinatorial immunotherapy: expanding the horizons with bispecific DART® molecules

10:40

Networking coffee break

Immune Profiling
11:30

Cancer neoantigens and their use in personalized cancer vaccines

Dr Bahram Bob Valamehr
Immune Profiling
12:00

Development of off-the-shelf immunotherapy from pluripotent cells

  • Pluripotent Cell Derived T and NK cells: Cornerstone Approach for Off-the-Shelf Cancer Immunotherapy
  • Use of small molecules and biologics, ex vivo, to optimize the biological properties and therapeutic function of hematopoietic cells
12:30

Networking Lunch & Poster Session

AFTERNOON PLENARY OF CONGRESS

last published: 22/Nov/17 13:35

 

DOWNLOAD DRAFT AGENDA

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

 

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

 

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

 

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071

 

 

Error processing SSI file